OREANDA-NEWS. Ajinomoto Co., Inc. announced its consolidated financial results for fiscal 2014 (April 1, 2013- March 31, 2014).

For the fiscal year ended March 31, 2014, net sales were JPY 991.3 billion (up JPY 6.3 billion) and operating income was JPY 62.5 billion (down JPY 8.6 billion), generally in line with the full-year forecast announced on February 14, 2014 in the release "Revisions to Consolidated Performance Forecast for the Fiscal Year Ending March 31, 2014."

Net sales increased JPY 6.3 billion compared with the previous fiscal year, with growth in sales of domestic seasonings and processed foods, frozen foods, specialty chemicals, amino acids and overseas consumer foods, as well as the positive effect of currency translation. Excluding the impact from the sale of Calpis Co., Ltd. (Calpis) and the spin-off of the infusion and dialysis business units, net sales would have increased JPY 80.3 billion. Operating income decreased due to factors including a decrease in income from feed-use amino acids and the absence of sales of Calpis products, which had been recorded until the previous fiscal year. Ordinary income decreased JPY 7.6 billion to JPY 69.5 billion (down 9.9%). Net income decreased JPY 5.5 billion to JPY 42.7 billion (down 11.5%) due to factors including posting a gain on transfer of benefit obligation relating to employees' pension fund in the previous fiscal year, and net income per share was JPY 69.70 (JPY 74.35 in the previous fiscal year).

Consolidated earnings of Ajinomoto Co., Inc. (Ajinomoto Co.) for the fiscal year ended March 31, 2014 were as follows.